Physician profile
Steven J Simerville
NPI 1497712921
$1,918.75
in general payments reported to CMS, 2019-2025
20 companies · $763 in 2025
The $763 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.24 · 2022: $108 · 2023: $173 · 2024: $795 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,730.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $514.60 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $200.20 | 2022-2025 | Evenity, Prolia, Otezla |
| Novo Nordisk INC | $180.05 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $159.22 | 2024-2025 | |
| Pfizer INC. | $153.89 | 2024-2025 | |
| Lilly USA, LLC | $114.76 | 2021-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $113.92 | 2023-2024 | Ubrelvy |
| Aimmune Therapeutics, INC. | $85.17 | 2024-2025 | Zenpep |
| Kowa Pharmaceuticals America, INC. | $60.04 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $55.10 | 2025 | Shingrix, Arexvy, Bexsero |
| Mylan Specialty L.P. | $53.32 | 2024 | Yupelri |
| Biohaven Pharmaceutical Holding Company LTD. | $47.21 | 2022 | |
| Uswm, LLC | $33.22 | 2021 | |
| Exact Sciences Corporation | $32.14 | 2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $27.06 | 2024 | Inspire |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $22.67 | 2025 | Korlym |
| Alkermes, INC. | $19.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.23 | 2025 | Jardiance |
| Baxter Healthcare | $16.56 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Merck Sharp & Dohme LLC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Simerville listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.